Supporting Payer Treatment Reimbursement Decisions for Alzheimer’s Disease: DISCERN™ Test Provides Definitive Diagnosis of Alzheimer’s Disease and Degenerative Pathologies vs. Other Forms of Dementia
Alzheimer dementia with sparse amyloid–AD mimic or variant?
DISCERN™ Morphometric Imaging Assay for Alzheimer’s Disease Accurately informs diagnosis of Alzheimer’s Disease in early dementia, even in the presence of Mixed dementia
The Burden of Diagnosis: How physicians confront diagnosing Alzheimer’s disease with influx of patients seeking disease modifying therapies
FDA Approval of New Drug for Alzheimer’s Disease Underscores Need for DISCERN™ Accurate Diagnostic Testing Prior to Prescribing LEQEMBI™ and Finalizing Coverage
Honoring Caregivers, Patients and Families During Caregivers and Alzheimer’s Awareness Month
SYNAPS Dx Publishes First Autopsy-Confirmed Results for Identifying Alzheimer’s in Presence of Other Co-Morbid Pathologies Using DISCERN™ Test
Spotlighting Accurate, Early Diagnosis of Alzheimer’s Disease: World Alzheimer’s Month
Input your search keywords and press Enter.